Analysts See $1.55 EPS for Walgreens Boots Alliance, Inc. (WBA)

March 16, 2018 - By Kurt Siggers

 Analysts See $1.55 EPS for Walgreens Boots Alliance, Inc. (WBA)

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.55 EPS on March, 28 before the open.They anticipate $0.19 EPS change or 13.97 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.54B giving it 10.88 P/E if the $1.55 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 21.09 % EPS growth. The stock increased 0.15% or $0.1 during the last trading session, reaching $67.48. About 2.26M shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 16, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. As per Tuesday, June 7, the company rating was maintained by Bank of America. The company was maintained on Friday, September 8 by Needham. The firm earned “Buy” rating on Tuesday, January 9 by Needham. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Buy” rating given on Tuesday, February 13 by Loop Capital Markets. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Buy” rating given on Thursday, July 20 by Leerink Swann. The rating was downgraded by Wood on Friday, July 22 to “Underperform”. The firm earned “Outperform” rating on Wednesday, September 9 by Cowen & Co. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) earned “Buy” rating by Jefferies on Tuesday, September 5. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, October 6. The firm has “Outperform” rating given on Monday, October 31 by Wells Fargo.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $66.85 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 18.62 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: which released: “Walgreens Boots Alliance – What Keeps The Stock From Going Up?” on March 12, 2018. Also published the news titled: “Rite Aid Announces Continued Progress in Sale of Assets to Walgreens Boots …” on March 05, 2018.‘s news article titled: “Walgreens Boots Alliance appoints James Kehoe Global CFO” with publication date: March 08, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.